Hospice & Palliative Care Charlotte Region in Charlotte, North Carolina

Hospice & Palliative Care Charlotte Region is a medicare-certified hospice facility in Charlotte, North Carolina. It is a non-profit hospice and this hospice is a Freestanding Hospice. It is located at 1420 East Seventh Street in Charlotte, North Carolina. You can reach out to the office of Hospice & Palliative Care Charlotte Region via phone at (704) 375-0100.

Hospice & Palliative Care Charlotte Region is first approved in October, 1984 to provide medicare and/or medicaid services and its CMS certification number (CCN) is 341500. Atlanta is the CMS Regional Office responsible for the certification of this hospice.

Contact Information


Hospice & Palliative Care Charlotte Region
1420 East Seventh Street, Charlotte, NC, 28204
(704) 375-0100

News Archive

Roundup: HIV staff to be cut in Ga.; Abortion news in N.J., Mo.; Wis. Medicaid coverage in limbo

A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.

Northwestern scientists map brain circuit that processes temperature information

Innately, we pull our hand away when we touch a hot pan on the stove, but little is known about how our brain processes temperature information. Northwestern University scientists now have discovered how a fruit fly's brain represents temperature, mapping it neuron by neuron, which has implications for understanding the much more complex human brain and how it responds to sensory stimuli.

TGen, UA receive NFCR grant to study targeted pancreatic cancer therapies

The Translational Genomics Research Institute (TGen) and the University of Arizona (UA) have received a three-year, $600,000 grant to study targeted cancer therapies from the National Foundation for Cancer Research.

Imricor to present results from MRI-guided cardiac ablation study at Heart Rhythm Society conference in Boston

Imricor Medical Systems announced today that the results from the clinical study to evaluate Imricor's Vision-MRTM Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance will be presented this week at the Heart Rhythm Society (HRS) conference in Boston.

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

Read more Medical News

› Verified 2 days ago

Map and Direction



Hospice Profile

NameHospice & Palliative Care Charlotte Region
Location1420 East Seventh Street, Charlotte, North Carolina
Hospice ID341500
CategoryFreestanding Hospice
Ownership TypeVoluntary Non-profit - Private
Profit TypeNON-PROFIT
Accreditation Provider Accreditation Commission for Health Care (ACHC)
SSA county code590

News Archive

Roundup: HIV staff to be cut in Ga.; Abortion news in N.J., Mo.; Wis. Medicaid coverage in limbo

A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.

Northwestern scientists map brain circuit that processes temperature information

Innately, we pull our hand away when we touch a hot pan on the stove, but little is known about how our brain processes temperature information. Northwestern University scientists now have discovered how a fruit fly's brain represents temperature, mapping it neuron by neuron, which has implications for understanding the much more complex human brain and how it responds to sensory stimuli.

TGen, UA receive NFCR grant to study targeted pancreatic cancer therapies

The Translational Genomics Research Institute (TGen) and the University of Arizona (UA) have received a three-year, $600,000 grant to study targeted cancer therapies from the National Foundation for Cancer Research.

Imricor to present results from MRI-guided cardiac ablation study at Heart Rhythm Society conference in Boston

Imricor Medical Systems announced today that the results from the clinical study to evaluate Imricor's Vision-MRTM Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance will be presented this week at the Heart Rhythm Society (HRS) conference in Boston.

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

Read more Medical News

› Verified 2 days ago

NPI associated with this Hospice

A hospice usually have one NPI number but sometimes it may have multiple NPI numbers. We have found possible NPI number/s associated with Hospice & Palliative Care Charlotte Region from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1548398720
Organization NameHospice & Palliative Care Charlotte Region
Address7845 Little Ave Charlotte, North Carolina, 28226
Phone Number(704)375-0100

News Archive

Roundup: HIV staff to be cut in Ga.; Abortion news in N.J., Mo.; Wis. Medicaid coverage in limbo

A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.

Northwestern scientists map brain circuit that processes temperature information

Innately, we pull our hand away when we touch a hot pan on the stove, but little is known about how our brain processes temperature information. Northwestern University scientists now have discovered how a fruit fly's brain represents temperature, mapping it neuron by neuron, which has implications for understanding the much more complex human brain and how it responds to sensory stimuli.

TGen, UA receive NFCR grant to study targeted pancreatic cancer therapies

The Translational Genomics Research Institute (TGen) and the University of Arizona (UA) have received a three-year, $600,000 grant to study targeted cancer therapies from the National Foundation for Cancer Research.

Imricor to present results from MRI-guided cardiac ablation study at Heart Rhythm Society conference in Boston

Imricor Medical Systems announced today that the results from the clinical study to evaluate Imricor's Vision-MRTM Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance will be presented this week at the Heart Rhythm Society (HRS) conference in Boston.

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

Read more Medical News

› Verified 2 days ago


Quality of Patient Care at Hospice & Palliative Care Charlotte Region

Hospice staff should discuss treatment preferences and patient beliefs and values with patients and/or caregivers. They should also identify and provide interventions to address pain, shortness of breath and constipation (caused by opioids) to improve patient comfort and quality of life. Hospice & Palliative Care Charlotte Region has the following score in these measures of patient care.
Better than National Average Worse than National Average

Quality MeasureProvider ScoreNational Score
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care97.498.3
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care98.493.6
Patients who were checked for pain at the beginning of hospice care97.493.9
Patients who got a timely and thorough pain assessment when pain was identified as a problem81.977.7
Patients who were checked for shortness of breath at the beginning of hospice care99.397.3
Patients who got timely treatment for shortness of breath99.194.6
Patients taking opioid pain medication who were offered care for constipation97.493.3

News Archive

Roundup: HIV staff to be cut in Ga.; Abortion news in N.J., Mo.; Wis. Medicaid coverage in limbo

A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.

Northwestern scientists map brain circuit that processes temperature information

Innately, we pull our hand away when we touch a hot pan on the stove, but little is known about how our brain processes temperature information. Northwestern University scientists now have discovered how a fruit fly's brain represents temperature, mapping it neuron by neuron, which has implications for understanding the much more complex human brain and how it responds to sensory stimuli.

TGen, UA receive NFCR grant to study targeted pancreatic cancer therapies

The Translational Genomics Research Institute (TGen) and the University of Arizona (UA) have received a three-year, $600,000 grant to study targeted cancer therapies from the National Foundation for Cancer Research.

Imricor to present results from MRI-guided cardiac ablation study at Heart Rhythm Society conference in Boston

Imricor Medical Systems announced today that the results from the clinical study to evaluate Imricor's Vision-MRTM Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance will be presented this week at the Heart Rhythm Society (HRS) conference in Boston.

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

Read more Medical News

› Verified 2 days ago


Services Provided by Hospice & Palliative Care Charlotte Region:

Hospice provide various services either through their own staff or through third-party arrangements. Find the list of services provided by Hospice & Palliative Care Charlotte Region below:
  • By staff
    • Home Health Aide Service
    • Counseling Service
    • Medical Social Service
    • Medical Supply Service
    • Nursing Service
    • Physician Service

  • Under Arrangement
    • Occupational Therapy
    • Physical Therapy
    • Short Term Inpatient care
    • Speech Pathology

  • Combination of Staff and Under Arrangement
    • No services

  • Type of Short Term Inpatient Care
    • Acute and Respite

Number of Full-time equivalent Employees:

Number of full time equivalent employees at Hospice & Palliative Care Charlotte Region
Home Health Aides17.26
Counselors2.53
Licensed Practical or Vocational Nurses2
Medical Social Workers 21.82
Physicians6.65
Registered Nurses79.71
Other Personnel93.94
Total Employees223.91

News Archive

Roundup: HIV staff to be cut in Ga.; Abortion news in N.J., Mo.; Wis. Medicaid coverage in limbo

A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.

Northwestern scientists map brain circuit that processes temperature information

Innately, we pull our hand away when we touch a hot pan on the stove, but little is known about how our brain processes temperature information. Northwestern University scientists now have discovered how a fruit fly's brain represents temperature, mapping it neuron by neuron, which has implications for understanding the much more complex human brain and how it responds to sensory stimuli.

TGen, UA receive NFCR grant to study targeted pancreatic cancer therapies

The Translational Genomics Research Institute (TGen) and the University of Arizona (UA) have received a three-year, $600,000 grant to study targeted cancer therapies from the National Foundation for Cancer Research.

Imricor to present results from MRI-guided cardiac ablation study at Heart Rhythm Society conference in Boston

Imricor Medical Systems announced today that the results from the clinical study to evaluate Imricor's Vision-MRTM Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance will be presented this week at the Heart Rhythm Society (HRS) conference in Boston.

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

Read more Medical News

› Verified 2 days ago


Number of Full-time equivalent Volunteers:

Others442
Total Volunteers442

News Archive

Roundup: HIV staff to be cut in Ga.; Abortion news in N.J., Mo.; Wis. Medicaid coverage in limbo

A loss of $3.7 million in federal funds is forcing Georgia to reduce its workforce for HIV prevention. After an inquiry by Georgia Health News, the Department of Public Health this week acknowledged that 20 people in state health districts have been notified they will probably lose their jobs in January, and that an unspecified number of staffers at the department level have received the same notification.

Northwestern scientists map brain circuit that processes temperature information

Innately, we pull our hand away when we touch a hot pan on the stove, but little is known about how our brain processes temperature information. Northwestern University scientists now have discovered how a fruit fly's brain represents temperature, mapping it neuron by neuron, which has implications for understanding the much more complex human brain and how it responds to sensory stimuli.

TGen, UA receive NFCR grant to study targeted pancreatic cancer therapies

The Translational Genomics Research Institute (TGen) and the University of Arizona (UA) have received a three-year, $600,000 grant to study targeted cancer therapies from the National Foundation for Cancer Research.

Imricor to present results from MRI-guided cardiac ablation study at Heart Rhythm Society conference in Boston

Imricor Medical Systems announced today that the results from the clinical study to evaluate Imricor's Vision-MRTM Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance will be presented this week at the Heart Rhythm Society (HRS) conference in Boston.

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

Read more Medical News

› Verified 2 days ago

Certification Details for Hospice & Palliative Care Charlotte Region:

  • November, 2006 is the initial visit of the health survey for certifications by CMS.
  • It is in compliance at the time of certification survey by CMS.
  • It is eligible to participate in the medicare and/or medicaid program.
  • Blue Cross (south Carolina) is the Medicare Administrative Contractor (MAC), intermediary or carrier servicing this hospice.
  • Current status is Active Provider.
  • Reason of certification is Recertification.
  • End of fiscal year is on 31, December.

Hospices in Charlotte

Hospice & Palliative Care Charlotte Region
Location: 1420 East Seventh Street, Charlotte, North Carolina, 28204
Phone: (704) 375-0100
Novant Health Hospice And Palliative Care A Develo
Location: 324 N Mcdowell Street, Charlotte, North Carolina, 28204
Phone: (704) 375-0100

Medicare Hospice Care

What is Hospice Care?
Hospice care is a type of care and philosophy of care that focuses on the palliation of a chronically ill, terminally ill or seriously ill patient's pain and symptoms, and attending to their emotional and spiritual needs. Care may be provided in a patient's home or in a designated facility such as nursing home, hospital unit or freestanding hospice, with level of care and sometimes location based upon frequent evaluation of the paients needs. The four primary levels of care provided by hospice are routine home care, continuous care, general inpatient and respite care.

How long can one get medicare hospice care?
Hospice care is for people with a life expectancy of 6 months or less (if the disease runs its normal course). If the person receiving hospice care live longer than 6 months, he or she can still get hospice care.
  • A person can get hospice care for two 90-day benefit periods, followed by an unlimited number of 60-day benefit periods.
  • At the start of each period, the hospice medical director or other hospice doctor must recertify that the person is terminally ill (with a life expectancy of 6 months or less). This step is must for continued hospice care.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.